Effects of perfluorooctanesulfonate and perfluorobutanesulfonate on the growth and sexual development of Xenopus laevis
- 687 Downloads
Perfluorobutanesulfonate (PFBS), as a substitute for perfluorooctanesulfonate (PFOS), is widespread in the environment and biotic samples as well as PFOS. To investigate effects of PFOS and PFBS on the growth and sexual development of amphibians, we exposed Xenopus laevis tadpoles at a series of concentrations of PFOS and PFBS (0.1; 1; 100; 1,000 μg/l) as well as 17-beta-estradiol (E2, 100 ng/l) and 5 alpha-androstan-17-beta-ol-3-one (DHT, 100 ng/l) from stage 46/47 to 2 months postmetamorphosis. We found that neither PFOS nor PFBS had a significant effect on the survival and growth. However, they caused hepatohistological impairment at higher concentrations (100; 1,000 μg/l). Unlike E2, PFOS at all concentrations did not alter the sex ratio and induce intersex, but caused degeneration of spermatogonia in testes except for the lowest concentration. PFBS had no effect on the sex ratio and gonadal histology. PFOS and PFBS promoted expression of estrogen receptor (ER) and androgen receptor (AR), but not affected aromatase expression in the brain. The increase in expression of ER and AR suggests an increase in the responsiveness to the corresponding sex hormone and potential effects on sexual development. Our results show that PFBS as well as PFOS have adverse effects on hepato-histology and sexual development on X. laevis. Also, PFOS- and PFBS-induced increase in ER and AR expression highlights the need to further study effects of PFOS and PFBS on subsequently gonadal development, sexual dimorphism, and secondary sex characteristics in X. laevis. It is debatable that PFBS is widely used as a substitute of PFOS.
KeywordsPerfluorooctanesulfonate (PFOS) Perfluorobutanesulfonate (PFBS) Growth Sexual development Xenopus laevis Brain
This work was supported by Grants from Hi-Tech Research and Development Program of China (863 Plan) (2010AA 065105), Public Welfare Research Project (201109048, 201110250), and National Natural Science Foundation of China (21077125).
Conflict of interest
The authors declare that they have no conflict of interest.
- Ankley GT, Kuehl DW, Kahl MD, Jensen KM, Linnum A, Leino RL, Villeneuvet DA (2005) Reproductive and developmental toxicity and bioconcentration of perfluorooctanesulfonate in a partial life-cycle test with the fathead minnow (Pimephales promelas). Environ Toxicol Chem 24(9):2316–2324CrossRefGoogle Scholar
- Bijland S, Rensen PC, Pieterman EJ, Maas AC, van der Hoorn JW, van Erk MJ, Havekes LM, van Dijk KW, Chang SC, Ehresman DJ, Butenhoff JL, Princen HM (2011) Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice. Toxicol Sci 123(1):290–303CrossRefGoogle Scholar
- Butenhoff JL, Olsen GW, Pfahles-Hutchens A (2006) The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum. Environ Health Perspect 114(11):1776–1782Google Scholar
- Cevasco A, Urbatzka R, Bottero S, Massari A, Pedemonte F, Kloas W, Mandich A (2008) Endocrine disrupting chemicals (EDC) with (anti)estrogenic and (anti)androgenic modes of action affecting reproductive biology of Xenopus laevis: II. Effects on gonad histomorphology. Comp Biochem Physiol 147(2):241–251Google Scholar
- DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI (2009) Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39(1):76–94CrossRefGoogle Scholar
- Elcombe CR, Elcombe BM, Foster JR, Chang SC, Ehresman DJ, Butenhoff JL (2012) Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPAR alpha and CAR/PXR. Toxicology 293(1–3):16–29CrossRefGoogle Scholar
- Gallien L (1953) Inversion totale du sexe chez Xenopus laevis Daud a la suite dun traitement gynogene par le benzoate doestradiol, administre pendant la vie larvaire. CR Hebd Acad Sci 237(23):1565–1566Google Scholar
- Gallien L (1956) Inversion experimentale du sexe chez un anoure inferieur Xenopus laevis Daudin. Analyse des consequences genetiques. Bull Biol Fr Belg 90:163–183Google Scholar
- Kelley FN (1992) Industry–university cooperation in polymer research. Abstr Pap Am Chem Soc 204:88Google Scholar
- Nieuwkoop PD, Faber J (1994) Normal table of Xenopus laevis, 2nd edn. Garland, New YorkGoogle Scholar
- Onishchenko AL, Kolbasko AV, Chernysheva AD, Surzhikova GS, Dantsiger OV (2011) Plasmapheresis combined with cell mass ozonation in endogenous uveitis treatment. Vestn Oftalmol 127(6):32–35Google Scholar
- Sen A, Prizant H, Hammes SR (2011) Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology. Steroids 76(9):822–828Google Scholar
- State Science and Technology Commission in China (1988) Regulation for the administration of affairs concerning experimental animals. The Ministry of Science and Technology of the People’s Republic of China, BeijingGoogle Scholar
- Villalpando I, Merchant-Larios H (1990) Determination of the sensitive stages for gonadal sex-reversal in Xenopus laevis tadpoles. Int J Dev Biol 34(2):281–285Google Scholar
- Zhao XL, Cai YQ, Wu FC, Pan YY, Liao HQ, Xu BB (2011) Determination of perfluorinated compounds in environmental water samples by high-performance liquid chromatography–electrospray tandem mass spectrometry using surfactant-coated Fe3O4 magnetic nanoparticles as adsorbents. Microchem J 98(2):207–214CrossRefGoogle Scholar